Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest GlaxoSmithKline Stories

2013-07-29 08:25:32

ZURICH-SCHLIEREN, Switzerland, July 29, 2013 /PRNewswire/ -- Following recently signed collaborations with GlaxoSmithKline Biologicals (GSK) and Janssen Pharmaceuticals (JPI), GlycoVaxyn AG, a leader in the development of innovative conjugate vaccines, today announced that it has secured a Strategic Translation Award from the Wellcome Trust to finance its Shigella program. The award will allow the Company to advance its Shigella bioconjugate vaccine by funding human safety and...

2013-07-25 16:25:12

Winners to be Recognized by Research and Academic Leaders at October 22 NYC Award Ceremony NEW YORK, July 25, 2013 /PRNewswire/ -- The Galien Foundation today announced the 2013 nominees for the seventh annual Prix Galien Awards. The Prix Galien Award is considered the biomedical industry's highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices. (Logo:...

2013-07-24 08:29:50

LONDON, July 24, 2013 /PRNewswire/ -- Simon Dingemans, CFO, outlines the UK pharma group's Q2 performance, positive R&D pipeline news, as well as outlook and guidance for the rest of the year. Dingemans also gives an update on his financial strategy plan, saying, "you could see in the second quarter the benefits of the restructuring programmes and some of the financial efficiencies we've identified really contributing to drive that leverage through the P&L and...

2013-07-23 08:30:12

PITTSBURGH, July 23, 2013 /PRNewswire/ -- Mylan Inc. (NASDAQ: MYL) today announced that the Third Circuit Court of Appeals has reversed a summary judgment ruling dismissing Mylan's claim for breach of contract against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release (ER) Tablets. The court ordered that Mylan's contract claim proceed to trial in U.S. District Court for the District of New Jersey. Mylan had filed suit against GSK claiming that GSK's agreement to...

2013-07-16 14:10:45

Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains. The authors of a study published in mBio®, the online open-access journal of the American Society for Microbiology, characterized viruses taken from the first person known to be stricken with H7N9 influenza and found...

2013-07-15 16:23:55

PARSIPPANY, N.J., July 15, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal(®) ODT. Actavis intends to launch the product immediately. As a "first applicant" to submit a substantially complete ANDA, Actavis may be...

2013-07-12 23:19:38

Viral resistance toward Acyclovir, which has been used for more than 20 years, is on the rise according to a study published in the Proceedings of the National Academy of Sciences (PNAS) in April 2013. (1) polyDNA recommends Gene-Eden-VIR, a natural antiviral, against latent herpes. Rochester, NY (PRWEB) July 12, 2013 Acyclovir and related drugs are the current drugs of choice for the treatment of herpes infection and viral reactivation. Now, a new study, which builds upon previous...

2013-07-12 23:17:58

Zebulon Tech of Pittsburgh has agreeded to promote G.S. Kyle's new book "Molon Labe". The controversial author is forecasting a Second American Civil War. Pittsburgh, PA (PRWEB) July 12, 2013 In the new revolution, an emerging powerhouse called Zebulon Tech may be perhaps the most important player to take the battle field. When author G.S.Kyle sent a free advance copy of his new book The Revolution Begins, to Zebulon Tech, his hope was that the emerging Internet marketing...

2013-07-11 08:28:59

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 11, 2013 /PRNewswire/ -- On Wednesday, July 10, 2013, shares in major drug manufacturers ended higher even as the broader market finished on a mixed note. The major movers in the industry included AstraZeneca Plc (ADR) (NYSE: AZN), GlaxoSmithKline Plc (ADR) (NYSE: GSK), Keryx Biopharmaceuticals (NASDAQ: KERX), and Raptor Pharmaceuticals Corp. (NASDAQ: RPTP). All these companies are...

2013-07-08 23:00:11

The Michigan Paxil lawyers are now accepting Paxil lawsuits for women who took the SSRI drug during pregnancy resulting in alleged birth defects to newborn. Southfield, MI (PRWEB) July 09, 2013 The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Paxil lawsuits and all other SSRI antidepressants cases that involve women that took an SSRI during their pregnancy resulting in their child being born with an alleged birth...